Press Releases

NASHVILLE, Tenn. , Aug. 11, 2020 /PRNewswire/ --  Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology, today provided a company update and announced second quarter 2020 financial results.

NASHVILLE, Tenn. , Aug. 4, 2020 /PRNewswire/ -- Cumberland Pharmaceuticals Inc.   (NASDAQ: CPIX) announced today that it will release second quarter 2020 financial results and Company update after the market closes on Tuesday, Aug. 11, 2020 . A conference call and live internet webcast will be held

New study shows use of Caldolor® prolongs time to first narcotic administration NASHVILLE, Tenn. , July 20, 2020 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, today announced the results of a Level 1 Trauma Center study recently published in the

NASHVILLE, Tenn. (July 1, 2020) – Cumberland Emerging Technologies, Inc. (CET)

NASHVILLE, Tenn. (Monday, June 15, 2020) – Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a U.S. specialty pharmaceutical company, announces the availability of the interim analysis data for a study of Vibativ® for patients with S Staphylococcus aureus

NASHVILLE, Tenn. , May 26, 2020 /PRNewswire/ --  Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) , a U.S. specialty pharmaceutical company, announces a new publication in Drugs - Real World Outcomes 1 , detailing the positive clinical outcomes with Vibativ ® in treating patients with bacteremia or

NASHVILLE, Tenn. , May 20, 2020 /PRNewswire/ --  Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology today provided a company update and announced first quarter 2020 financial results.

NASHVILLE, Tenn. , May 15, 2020 /PRNewswire/ --  Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today that it will release first quarter 2020 financial results and a Company update after the market closes on Wednesday, May 20, 2020 . A conference call and live Internet webcast will be

NASHVILLE, Tenn. , May 11, 2020 /PRNewswire/ --  Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) , a U.S. specialty pharmaceutical company announces two new publications detailing the sustained in vitro potency of Vibativ ® (telavancin) as part of a 7-year antimicrobial surveillance program.

Includes Details About Company's Community Involvement, Ethical Marketing & Drug Safety NASHVILLE, Tenn. , April 28, 2020 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, today released its first Sustainability Report.